[Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)]
- PMID: 381768
- DOI: 10.1007/BF01477628
[Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)]
Abstract
The following pathogenetic mechanisms, exemplified by three diseases (diabetes mellitus, hyperthyroidism and familial hypercholesterolemia), are discussed: 1. The impaired interaction between a chemical signal and a specific receptor can be the cause of a disease. 2. The cause for an imparied interaction can be a defect of the receptor, i.e., a reduced number of receptors or an altered receptor affinity, or a wrong signal. 3. A defect of the receptor can be induced by exogenous influences or it can be determined genetically. 4. The receptor and the signal can be modified by their interaction: the number of receptors is reduced by high concentrations of the chemical signal or by increased degradation due to binding to the receptor. 5. The receptor concept opens new perspectives for the pathogenetic understanding, diagnosis and therapy of some diseases.
Similar articles
-
[Receptor dysfunction as a pathogenetic principle in hormone resistance and metabolic diseases].Schweiz Med Wochenschr. 1981 Feb 7;111(6):174-81. Schweiz Med Wochenschr. 1981. PMID: 6261324 Review. German.
-
Mechanisms of Graves' disease and endocrine exophthalmos.Am J Ophthalmol. 1969 Jul;68(1):46-57. doi: 10.1016/0002-9394(69)94934-4. Am J Ophthalmol. 1969. PMID: 4895778 Review. No abstract available.
-
[Studies on insulin resistance and insulin receptor binding to erythrocytes in childhood obesity and diabetes mellitus (author's transl)].Horumon To Rinsho. 1981 Feb;29(2):185-90. Horumon To Rinsho. 1981. PMID: 7261436 Japanese. No abstract available.
-
The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator.J Endocrinol. 1974 Jun;61(3):437-45. doi: 10.1677/joe.0.0610437. J Endocrinol. 1974. PMID: 4366120 No abstract available.
-
The metabolism of iodotyrosines. I. The fate of mono- and di-iodotyrosine in normal subjects and in patients with various diseases.J Clin Endocrinol Metab. 1956 Jun;16(6):735-46. doi: 10.1210/jcem-16-6-735. J Clin Endocrinol Metab. 1956. PMID: 13319468 No abstract available.